The higher efficacy of chitosan nanoparticles loaded with recombinant HP-NAP against breast cancer in mice could be due to the reason that chitosan nanoparticles act as adjuvants to the main immunotherapy protein [86]. This evidence concerns the gene HP and breast cancer.